Evidence map›Paper›PMID 31086666›Full record

ArticleMolecular and clinical oncology2019

Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment.

Yoshinori Fujiwara, Shuichi Fukuda, Masanori Tsujie, Kotaro Kitani, Masao Yukawa, Masatoshi Inoue, Yusaku Watanabe, Masaharu Higashida, Hisako Kubota, Toshimasa Okada and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yoshinori FujiwaraDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Shuichi FukudaDepartment of Surgery, Nara Hospital, Kindai University, Ikoma, Nara 630-0293, Japan.
Masanori TsujieDepartment of Surgery, Nara Hospital, Kindai University, Ikoma, Nara 630-0293, Japan.
Kotaro KitaniDepartment of Surgery, Nara Hospital, Kindai University, Ikoma, Nara 630-0293, Japan.
Masao YukawaDepartment of Surgery, Nara Hospital, Kindai University, Ikoma, Nara 630-0293, Japan.
Masatoshi InoueDepartment of Surgery, Nara Hospital, Kindai University, Ikoma, Nara 630-0293, Japan.
Yusaku WatanabeDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Masaharu HigashidaDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Hisako KubotaDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Toshimasa OkadaDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Atsushi TsurutaDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Tomio UenoDepartment of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
Kawasaki Medical School · JPKindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study used inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) to compare survival benefits among 112 patients with resectable, stage II-IV esophageal squamous cell carcinoma (SCC) treated between 1996 and 2016 with neoadjuvant chemoradiotherapy (NAC) plus surgery (Group A,

Indexed as

chemoradiotherapyesophageal canceresophagectomypropensity score

Identifiers

PMID31086666
PMCPMC6488943
OpenAlexW2940231871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.